Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT02387216
Title A Study of MM-121 in Combination With Chemotherapy Versus Chemotherapy Alone in Heregulin Positive NSCLC
Acronym SHERLOC
Recruitment Terminated
Gender both
Phase Phase II
Variant Requirements Yes
Sponsors Merrimack Pharmaceuticals
Indications
Therapies
Age Groups: adult
Covered Countries USA | HUN | FRA | ESP | DEU | CAN

Additional content available in CKB BOOST